Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Watch Mylan May be Bought by Teva for $40.1B - Bloomberg
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Drug giant to fight price-fixing charges
13 Billionaire Phillip Frost Interview As Opko Health Inc Lists On Tel Aviv Stock Exchange Photos and Premium High Res Pictures - Getty Images
Teva Pharmaceuticals - Wikipedia
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement | Ctech
Eyal Desheh, chief financial officer of TEVA Pharmaceutical... News Photo - Getty Images
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva Drug-Label Case Spurs Fresh Litigation as Judges Weigh Redo
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state - KTVZ
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva's Budding Blockbusters Lend Respite From Legal Concerns
Drugmaker Teva to cut workforce by 10% | Financial Times
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Watch How to Trade Teva Pharmaceutical - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
